Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:14 PM
Study NCT ID:
NCT06281158
Status:
COMPLETED
Last Update Posted:
2024-06-20
First Post:
2024-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-DNL343 Following a Single Oral Dose in Healthy Male Participants
Sponsor:
Denali Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-20
First Submit QC Date:
None
Study First Post Date:
2024-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-17
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL